Company intelligence / Profile preview

NeuroStorm

New York, New York, United Statesxinliu.engineering.ucdavis.edu ↗

Ownership: Private
Development stage: Other

Overview

NeuroStorm has developed proprietary algorithms that eliminate or reduce parkinsonian tremors within virtual reality environments. These solutions allow patients to function normally in VR, with reported real-world benefits including reduced physical tremors outside of VR. The company is working to bring this technology to market as an FDA-regulated Software as a Medical Device that could be prescribed by physicians similarly to drugs or surgical tools. Clinical results are not detailed but early testing is referenced.

Therapeutic areas: Neurology
Modalities: DeviceSoftware as a Medical Device (SaMD)Digital medicine
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on NeuroStorm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuroStorm.

Explore the full profile